Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine infiltration for postoperative analgesia after perianal surgery
ACTRN12626001085369Phase 4Not yet recruiting
- Sponsor
- Fatima Memorial Hospital
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hemorrhoid, anal fistula and chronic anal fissure (CAF) comparing Ropivacaine infiltration with Normal saline placebo infiltration (2 arms). Primary endpoint: Postoperative pain score. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
hemorrhoidanal fistulachronic anal fissure (CAF)
Beyond the preview
Go deeper on ACTRN12626001085369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626001085369.